Elena Martinez, Moores Cancer Center
Ian Komenaka, Maricopa Medical Center
Time: 10:00AM Pacific, 1:00PM Eastern.
Little is known about willingness of individuals from underserved populations to participate in biospecimen collection and data sharing, and whether participation varies according to the individual who is attempting to obtain informed consent from patients for such participation. We propose to conduct a pilot study to compare two methods of informed consent delivery for biospecimen collection in a population of individuals receiving care at a safety net health care setting in the Phoenix, Arizona metropolitan area. We specifically aim to: (1) Compare the rate of informed consent for biospecimen collection and data sharing for research solicited by a physician with the rate of informed consent solicited through a research assistant; (2) Explore differences in informed consent delivery by the following factors: age, race/ethnicity, health literacy, cancer risk perception, language use, and breast cancer vs. non-cancer diagnosis.
Elena Martinez, PhD is Professor in the Department of Family and Preventive Medicine, having joined the UC San Diego faculty in 2012. She holds the Sam M. Walton Endowed Chair for Cancer Research and Co-leads the Reducing Cancer Disparities Program at the Moores Cancer Center. Dr. Martinez holds a PhD in Epidemiology and a Master’s in Public Health. Dr. Martinez’s research interests in colorectal cancer prevention began during the conduct of her doctoral dissertation and extended into her post-doctoral studies at the Harvard School of Public Health. She had a very active research portfolio at the University of Arizona, including RO1 funding and program leadership in a Program Project (PO1) and a Specialized Program of Research Excellence (SPORE) program. She has published extensively in areas of epidemiology, molecular epidemiology, and cancer prevention. Her research currently focuses on breast cancer in Hispanic women, with a prominent leadership role in the Ella Binational Breast Cancer Study. Nationally, she has established herself as a strong leader in the area of cancer health disparities; evidence of this is her appointment as recent chair of the American Association for Cancer Research Minorities in Cancer Research Council.
Dr. Ian Komenaka is the Breast surgical oncologist at Maricopa Medical Center, which is the county, safety net hospital Phoenix, AZ. The population seen in my Breast Clinic is 90% underinsured or uninsured and 60% minorities. This makes Maricopa Medical Center an ideal site for recruitment of patients not normally involved in prospective trials. Maricopa Medical Center has established a track record of successfully recruiting minority patients to prospective studies, such as the ELLA Binational Study and the City of Hope Genetic Cancer Risk Assessment Prospective Registry. More recently, he completed training with Dr. Jeffrey Weitzel, a leading expert in Genetic Cancer Risk Assessment Counseling at City of Hope and has been able to provide a service to this underserved patient population that was previously not available.
IMPORTANT NOTICE: This ReadyTalk service includes a feature that allows audio and any documents and other materials exchanged or viewed during the session to be recorded. By joining this session, you automatically consent to such recordings. If you do not consent to the recording, discuss your concerns with the meeting host prior to the start of the recording or do not join the session. Please note that any such recordings may be subject to discovery in the event of litigation.